Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol])

Joel A. Vilensky, Wendy M. Robertson, Sid Gilman

Research output: Contribution to journalShort survey

12 Scopus citations


In 1951 Denny-Brown and Porter described the successful treatment of Wilson's disease using the chelating agent British antilewisite. The presentation of their results both at meetings and in print changed the traditional view of neurology from a descriptive to an interventional discipline using treatments based on the underlying biochemical disorder. The authors review the importance of these reports and provide edited digital versions of the films Denny-Brown made of the five patients described in the initial reports.

Original languageEnglish (US)
Pages (from-to)914-916
Number of pages3
Issue number6
StatePublished - Sep 24 2002

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Denny-Brown, Wilson's disease, and BAL (British antilewisite [2,3-dimercaptopropanol])'. Together they form a unique fingerprint.

  • Cite this